BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3697150)

  • 1. 2'-fluorinated pyrimidine isonucleosides. Novel nucleoside analogs demonstrate therapeutic activity in mice with tumors.
    Bobek M; An SH; Skrincosky D; De Clerq E; Bernacki RJ
    Nucleic Acids Symp Ser; 1987; (18):5-7. PubMed ID: 3697150
    [No Abstract]   [Full Text] [Related]  

  • 2. Preparation and biological activity of 5,6-dihydro-5-azapyrimidine nucleosides.
    Pískala A; Cesneková B; Veselý J
    Nucleic Acids Symp Ser; 1987; (18):57-60. PubMed ID: 3697151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapeutic characterization in mice of 2-amino-9-beta-D-ribofuranosylpurine-6-sulfinamide (sulfinosine), a novel purine nucleoside with unique antitumor properties.
    Avery TL; Finch RA; Vasquez KM; Radparvar S; Hanna NB; Revankar GR; Robins RK
    Cancer Res; 1990 May; 50(9):2625-30. PubMed ID: 2328488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2'-Fluorinated isonucleosides. 1. Synthesis and biological activity of some methyl 2'-deoxy-2'-fluoro-2'-pyrimidinyl-D-arabinopyranosides.
    Bobek M; An SH; Skrincosky D; De Clercq E; Bernacki RJ
    J Med Chem; 1989 Apr; 32(4):799-807. PubMed ID: 2704026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of iodinated and fluorinated 9-(2-hydroxypropyl) and 9-(2-hydroxyethoxy)methyl purine nucleoside analogues.
    Prekupec S; Svedruzić D; Gazivoda T; Mrvos-Sermek D; Nagl A; Grdisa M; Pavelić K; Balzarini J; De Clercq E; Folkers G; Scapozza L; Mintas M; Raić-Malić S
    J Med Chem; 2003 Dec; 46(26):5763-72. PubMed ID: 14667229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isothiazolopyrimidines--new group of anticancer agents. I.
    Machoń Z; Wieczorek J; Mordarski M
    Arch Immunol Ther Exp (Warsz); 1987; 35(5):599-607. PubMed ID: 3455649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proceedings: Discussion of pattern recognition.
    Unger SH
    Cancer Chemother Rep 2; 1974 Dec; 4(4):45-6. PubMed ID: 4475613
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experimental findings concerning the anti-tumor properties of nordopan glucosides].
    Popov DV; Platonova GN; Studentsov EP; Larionov LF
    Biull Eksp Biol Med; 1973 May; 75(5):73-5. PubMed ID: 4778694
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis and antitumor activity of 7- and 9-(6'-deoxy-alpha-L-talofuranosyl) hypoxanthine and 9-(6'-deoxy-alpha-L-talofuranosyl)-6-thiopurine.
    Nelson V; El Khadem HS
    J Med Chem; 1983 Oct; 26(10):1527-30. PubMed ID: 6684690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic nucleosides and nucleotides. XIV. Facile synthesis and antitumor activities of 6-mercaptopurine 2'-deoxyriboside and related compounds.
    Saneyoshi M; Nishimura S; Okabe M; Fukuoka F
    J Pharmacobiodyn; 1980 Feb; 3(2):105-10. PubMed ID: 6162940
    [No Abstract]   [Full Text] [Related]  

  • 11. Experimental approach for the search of effective drug combination in cancer chemotherapy.
    Bello JL; Kariev NI; Mainardi JV; Betancourt M; Lage A; Barroso MC; Alfonso L
    Neoplasma; 1982; 29(1):65-71. PubMed ID: 7070556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antitumor evaluation in mice of certain 7-deazapurine (pyrrolo[2,3-d]pyrimidine) and 3-deazapurine (imidazo[4,5-c]pyridine) nucleosides structurally related to sulfenosine, sulfinosine, and sulfonosine.
    Ramasamy K; Imamura N; Hanna NB; Finch RA; Avery TL; Robins RK; Revankar GR
    J Med Chem; 1990 Apr; 33(4):1220-5. PubMed ID: 2319564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Compounds with potential antitumor activity. V. 2-Substituted 3-[2-(1,3,4-thiadazolyl)]-4-thiazolidinone].
    Chimirri A; Grasso S; Monforte P; Fenech G; Zappalà M
    Farmaco Sci; 1986 Nov; 41(11):839-51. PubMed ID: 3803563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methanesulfonates: the relationship of structure to antitumor activity.
    Sandberg JS; Wood HB; Engle RR; Venditti JM; Goldin A
    Cancer Chemother Rep 2; 1972 Nov; 3(1):137-229. PubMed ID: 4350012
    [No Abstract]   [Full Text] [Related]  

  • 15. Enhancement of antitumor effect of cyclophosphamide by thaliblastine in Lewis lung carcinoma and L1210 leukemia in mice.
    Stoychkov JN; Miloushev AS
    Biomedicine; 1980 Apr; 33(2):42-4. PubMed ID: 6447522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substituted hydroxylaminopurines and related derivatives. Synthesis and screening tests.
    Giner-Sorolla A; Burchenal JH
    J Med Chem; 1971 Sep; 14(9):816-9. PubMed ID: 5291026
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of 3-deazauridine on the metabolism, toxicity, and antitumor activity of azacitidine in mice bearing L1210 leukemia sensitive and resistant to cytarabine.
    Li ZR; Campbell J; Rustum YM
    Cancer Treat Rep; 1983 Jun; 67(6):547-54. PubMed ID: 6190558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basis for clinical resistance to antitumor nucleoside analogs.
    Hall TC
    Ann N Y Acad Sci; 1975 Aug; 255():235-43. PubMed ID: 1103683
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies on the antineoplastic action of N-methylisoindigotin].
    Ji XJ; Zhang FR; Liu Y; Gu QM
    Yao Xue Xue Bao; 1985 Apr; 20(4):247-51. PubMed ID: 4072694
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthesis and evaluation of 1-acyl-1,2-bis(methylsulfonyl)-2-(2- chloroethyl)hydrazines as antineoplastic agents.
    Shyam K; Penketh PG; Divo AA; Loomis RH; Rose WC; Sartorelli AC
    J Med Chem; 1993 Nov; 36(23):3496-502. PubMed ID: 8246218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.